BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$926M |
| 2 |
Sea Limited
SE
|
+$712M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$697M |
| 4 |
Wells Fargo
WFC
|
+$687M |
| 5 |
Blackstone
BX
|
+$652M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$16.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.4B |
| 3 |
Apple
AAPL
|
+$3.41B |
| 4 |
Microsoft
MSFT
|
+$3.3B |
| 5 |
Linde
LIN
|
+$2.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.52% |
| 2 | Healthcare | 13.51% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
AbCellera Biologics
ABCL
$1.86B
| $19.7M | ﹤0.01% |
897,187
+41,714
| +5% | +$1.15M |
|
3302
KALA BIO
KALA
$14.4M
| $19.7M | ﹤0.01% |
1,489
+161
| +12% | +$2.53M |
|
3303
Amalgamated Financial
AMAL
$1.49B
| $19.7M | ﹤0.01% |
1,260,468
-46
| -0% | -$745 |
|
3304
Compugen
CGEN
$225M
| $19.7M | ﹤0.01% |
2,378,179
-37,490
| -2% | -$304K |
|
|
GNTY
3305
DELISTED
Guaranty Bancshares
GNTY
| $19.7M | ﹤0.01% |
577,122
-55,573
| -9% | -$2.11M |
|
3306
Nomura Holdings
NMR
$28.5B
| $19.7M | ﹤0.01% |
3,861,133
-70,831
| -2% | -$381K |
|
3307
Distribution Solutions Group
DSGR
$1.61B
| $19.6M | ﹤0.01% |
732,414
-79,412
| -10% | -$2.19M |
|
|
LITS
3308
Lite Strategy Inc
LITS
$32.1M
| $19.6M | ﹤0.01% |
343,427
-29,685
| -8% | -$1.91M |
|
3309
Greenlight Captial
GLRE
$543M
| $19.5M | ﹤0.01% |
2,134,028
-131,831
| -6% | -$1.21M |
|
3310
Barclays
BCS
$94.5B
| $19.5M | ﹤0.01% |
2,017,240
+89,981
| +5% | +$919K |
|
3311
Santander
BSBR
$42.5B
| $19.4M | ﹤0.01% |
2,475,225
+98,225
| +4% | +$730K |
|
3312
Tilray
TLRY
$632M
| $19.4M | ﹤0.01% |
107,462
+68,144
| +173% | +$12M |
|
|
NBEV
3313
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
| $19.4M | ﹤0.01% |
8,710,620
+1,236,792
| +17% | +$2.88M |
|
|
LOTZ
3314
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
| $19.4M | ﹤0.01% |
3,551,129
+2,168,594
| +157% | +$13.7M |
|
|
DSKE
3315
DELISTED
Daseke, Inc. Common Stock
DSKE
| $19.3M | ﹤0.01% |
2,976,504
-470,424
| -14% | -$3.42M |
|
3316
Aegon
AEG
$13.9B
| $19.2M | ﹤0.01% |
4,948,596
-203,893
| -4% | -$868K |
|
3317
MetroCity Bankshares
MCBS
$1.03B
| $19.1M | ﹤0.01% |
1,093,356
+1,927
| +0.2% | +$32K |
|
3318
Utah Medical Products
UTMD
$230M
| $19.1M | ﹤0.01% |
224,845
-4,147
| -2% | -$359K |
|
3319
BlackBerry
BB
$5.2B
| $19.1M | ﹤0.01% |
1,559,682
-159,003
| -9% | -$1.67M |
|
|
SURF
3320
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $19M | ﹤0.01% |
2,544,933
+1,580,573
| +164% | +$12.2M |
|
3321
InfuSystem Holdings
INFU
$249M
| $19M | ﹤0.01% |
912,973
+100,278
| +12% | +$2.03M |
|
|
CAJ
3322
DELISTED
Canon, Inc.
CAJ
| $19M | ﹤0.01% |
838,447
+84,955
| +11% | +$2M |
|
3323
Vanguard Extended Market ETF
VXF
$31.5B
| $19M | ﹤0.01% |
100,512
+6,899
| +7% | +$1.26M |
|
3324
Wave Life Sciences
WVE
$1.18B
| $18.9M | ﹤0.01% |
2,839,335
-144,200
| -5% | -$942K |
|
3325
Plains GP Holdings
PAGP
$5.04B
| $18.9M | ﹤0.01% |
1,583,384
-116,016
| -7% | -$1.24M |
|
Similar funds
BlackRock's Q2 2021 Portfolio in Review
As of Q2 2021, BlackRock held 5,668 positions worth $3.59T, up 5.6% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
BlackRock's Q2 2021 filing shows 333 new, 2,001 increased, 2,748 reduced and 150 closed positions. Its largest new stake was Organon & Co: 16,503,495 shares worth $499M. The largest sale was Alibaba, an estimated $16.4B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2021 buy was Organon & Co: 16,503,495 shares worth $499M.
- BlackRock added most to Palantir in Q2 2021, an estimated $926M increase.
- BlackRock's biggest Q2 2021 reduction was Alibaba, cutting an estimated $16.4B.
- BlackRock fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.35B.
- BlackRock's ten largest holdings make up 18% of its $3.59T portfolio in Q2 2021.
- BlackRock opened 333 new positions and closed 150 in Q2 2021.
- BlackRock's portfolio value rose 5.6% quarter-over-quarter to $3.59T.
Based on BlackRock's 13F filing for Q2 2021, filed 11 Aug 2021.